Recently, Beijing Dongxi Analysis Instrument Co., Ltd. and Hangzhou Digital - Micro Biotech Co., Ltd. have officially reached a strategic cooperation, jointly committed to the technical upgrading and application expansion of rapid microbial mass spectrometry identification and environmental microbial risk control. As a leading enterprise in high - end analytical instruments in China, Dongxi Analysis has significant advantages in the R & D and manufacturing of mass spectrometers. Digital - Micro Biotech, on the other hand, focuses on microbial gene identification and big data analysis, providing risk identification and trend prediction services. The two sides will integrate hardware equipment and data analysis capabilities, focusing on improving the breadth and accuracy of microbial identification in fields such as pharmaceuticals, food safety, and cosmetics. The cooperation focuses on the pharmaceutical industry. Relying on time - of - flight mass spectrometry technology and an exclusive microbial database, it will build a closed - loop system from rapid identification, data analysis to risk warning, realizing dynamic monitoring and active management to ensure drug quality. This cooperation, through the deep integration of "hardware + data", promotes the microbial mass spectrometry technology to achieve more intelligent and efficient risk - decision - making support in several key areas.